NCT06782529RecruitingPhase 4
Knee Injections for Obese Patients With Knee Arthritis
Comparison of Varying Doses of Steroid for Intra-articular Knee Injections
Source: ClinicalTrials.gov · Last updated 10 Mar 2026
Brief summary (registry, in English)
The purpose of this study is to assess obese patients with knee arthritis and determine the non-inferiority of a low dose steroid treatment vs. standard dose steroid treatment for two knee outcome measures: pain and function.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 15 Jan 2025
- Start date
- 24 Jan 2025
- Primary completion date
- 24 Jan 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Obesity
- NCT number
- NCT06782529
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 40
- From 24 Jan 2025 to the primary completion date, 24 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients that are undergoing physical therapy at the time of the study.
Lab values
- Uncontrolled diabetics with a hemoglobin A1c \> 8%
Other
- BMI \< 30 kg/m2
- No other treatment within the time frame of the study.
Who the study is looking for
- Patients with BMI ≥30 kg/m2 and radiograph-proven knee osteoarthritis who are interested in receiving a steroid injection for knee arthritis.
Age in the registry: 55 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Florida Coordinator of this site? Confirm its status | Jacksonville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.